GoKawiilYC-backed RonanRX launches personalized, compounded GLP-1 peptide therapy
RonanRX, a Y Combinator S26 startup, has launched a service offering personalized, compounded GLP-1 medications tied to individual patient prescriptions rather than mass-produced doses. The company emphasizes a doctor-led, pharmacist-verified process for each preparation, with ongoing physician support throughout treatment.